Today’s top gainers include the company Incyte Corporation (NASDAQ:INCY) which is in the industry Biotechnology, gaining 0.99% today. In the last week its performance is 7.70%, and 0.75% for the past quarter. Currently, Incyte Corporation, INCY has a target price of 92, so today’s gain of 0.99% is a significant step towards its target price. The GAP today is therefore 0.06%.
Incyte Corporation (NASDAQ:INCY), has a market cap of 15438.94, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 99.10%.
At the current price of 83.3, it has a dividend yield of *TBA, and its target price is 92. This is with a profit margin of 5.70%, and total debt/equity of 0. Incyte Corporation (NASDAQ:INCY) has a P/E of 390.9, as well as a forward P/E of 63.15.
With a current EPS of 0.21, and a forecasted EPS growth for next year at 3527.78%,Incyte Corporation (NASDAQ:INCY) has had a EPS growth for the past five years at 16.40%. For the next five years EPS growth is projected to be 38.70%.
Performance for the year is -24.55%. Since its IPO date on 11/04/1993, the total performance to date is -23.95%.
Volume today for Incyte Corporation (NASDAQ:INCY), is 190246, while its average volume is 1150.43. Whilst the total gain today was 0.99%, it did have a day high of -5.21%.
Volatility for this week has been at 4.16%, and 4.24% for the month. The 52-week low for Incyte Corporation, INCY has been 51.45%, while the 52-week-high has reached -37.66%.
Looking at its return of investments, which is 6.30%, and its return on assets is 4.90%. Incyte Corporation (NASDAQ:INCY) has an operating margin of 10.90%. With a sales growth of 65.40% quarter over quarter. Bearing in mind that Incyte Corporation, INCY is in the sector Healthcare, its long-term debt/equity is 2.76, and has a current ratio of 4.7 and 4.7 for quick ratio.
So what is the value of Incyte Corporation? Well its PEG is 10.1, and the P/S is 18, along with a P/B of 67.61. Meanwhile it has a p/cash of 19.04.